Figure 3.
Effect of rondaptivon pegol on trough FVIII levels. Example of increasing FVIII trough levels under treatment with the VWF-binding aptamer rondaptivon pegol in a severe hemophilia patient on once-weekly prophylaxis with 4000 IU efmoroctocog alfa.